STE
STERIS plc
Is STE Halal?
Sterilization and infection prevention products with permissible business.
What You Should Know
STERIS provides sterilization and surgical products for healthcare facilities. Its March 31, 2026 Form 10-K reports $10,737.2 million of assets, $1,931.7 million of interest-bearing debt, $439.6 million of cash, $1,092.8 million of receivables and $5,935.9 million of fiscal-year revenue. Debt/assets is 17.99%, liquidity/assets is 4.09%, receivables-plus-cash/assets is 14.28% and disclosed interest and miscellaneous income is 0.17% of revenue; the examined FTSE, MSCI and Malaysia financial ratios pass.
⚠️ Concerns
- •Healthcare and laboratory customer end uses
- •Long-term indebtedness
- •Interest and miscellaneous income
Current quantitative Sharia screen
Based on 10-K figures for the period ended 2026-03-31; calculated 2026-07-15.
1,931.7 / 10,737.2
439.6 / 10,737.2
1,532.4 / 10,737.2
9.8 / 5,935.9
- Financial
- Pass
- Overall
- Pass
Debt/assets is 17.99%, liquidity/assets is 4.09%, receivables-plus-cash/assets is 14.28% and disclosed interest and miscellaneous income is 0.17% of revenue; examined FTSE ratios and core activity pass.
- Financial
- Pass
- Overall
- Pass
Debt/assets, liquidity/assets and receivables-plus-cash/assets are below the examined MSCI total-assets limits; this is not an index-membership claim.
- Financial
- Pass
- Overall
- Pass
Debt/assets and liquidity/assets pass the examined Malaysia limits; this is a calculation against the named ratios, not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored; filing-based financial results remain documented.
Business-activity disclosure
STERIS provides sterilization, infection-prevention and surgical products and services for healthcare and life-sciences customers. The core activity is generally permissible.
Limitation: The filing does not allocate every healthcare, laboratory or customer end use into a scholar-approved prohibited-revenue numerator.
Purification
STERIS discloses $9.8 million of interest and miscellaneous income but does not provide a scholar-approved purification percentage or separate prohibited-activity numerator.
Inputs, assumptions and primary sources
- Amounts are USD millions from STERIS's March 31, 2026 Form 10-K.
- Interest-bearing debt includes $118.9 million of short-term indebtedness and $1,812.8 million of long-term indebtedness; lease obligations are excluded.
- Cash is $439.6 million and no separately identifiable interest-bearing securities are reported in the selected balance-sheet captions.
- Accounts receivable are $1,092.8 million net; fiscal-year revenue is $5,935.9 million.
- Interest and miscellaneous income is $9.8 million and is used as the disclosed-income proxy.
- Sterilization, infection prevention, surgical and life-sciences products are treated as generally permissible; customer end uses remain qualitative review items.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →